Showing 1 - 20 results of 5,666 for search '(( sub ((a decrease) OR (mean decrease)) ) OR ( i ((largest decrease) OR (marked decrease)) ))', query time: 0.48s Refine Results
  1. 1

    Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

    Published 2025
    “…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …”
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

    Published 2025
    “…<p>(A) Bar graph showed EVO significantly decreased Lactate dehydrogenase (LDH) release in CER treated P<sub>i</sub>‐induced VSMCs. …”
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    PBP1 depletion results in a population of cells with decreased RADA fluorescence. by Gregory A. Harrison (16639446)

    Published 2025
    “…Note that the P<sub>tet</sub>-<i>gusA</i> data from panel A (blue squares) was duplicated in panel B for comparison. >1300 cells were quantified across three independent experiments, and symbols represent the mean and standard error of the mean from three replicates.…”
  14. 14

    Changes in the active H3K27ac and repressive H3K27me3 histone marks among Vasa2+/Piwi1+ and all cells in fed, starved, and refed juvenile polyps. by Eudald Pascual-Carreras (12115380)

    Published 2025
    “…See <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003525#pbio.3003525.s017" target="_blank">S6 Table</a> for mean values and statistical data and <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003525#pbio.3003525.s020" target="_blank">S1 Data</a> for individual numerical values.…”
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20